Fig. 5From: Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics Ovarian cancer biomarker peptides were identified in biospecimens. Bar graph showing the number of a unique peptides, or b spectra identified in the Pap test fluid, the tumor tissue extract, and cervical swabs for three ovarian cancer biomarkersBack to article page